United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - menadiol sodium phosphate - oral tablet - 10mg

United States - English - NLM (National Library of Medicine)

pharmacia & upjohn company llc - estradiol cypionate (unii: 7e1dv054lo) (estradiol - unii:4ti98z838e) - estradiol cypionate 5 mg in 1 ml - depo-estradiol injection is indicated in the treatment of: estrogens should not be used in individuals with any of the following conditions: there appears to be little or no increased risk of birth defects in children born to women who have used estrogens and progestins from oral contraceptives inadvertently during early pregnancy. (see precautions.) chlorobutanol anhydrous (chloral derivative) added as a preservative may be habit forming.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - estradiol cypionate (unii: 7e1dv054lo) (estradiol cypionate - unii:7e1dv054lo) - estradiol cypionate 5 mg in 1 ml - depo-estradiol injection is indicated in the treatment of: - moderate to severe vasomotor symptoms associated with the menopause. - hypoestrogenism due to hypogonadism. estrogens should not be used in individuals with any of the following conditions: - undiagnosed abnormal genital bleeding. - known or suspected cancer of the breast. - known or suspected estrogen-dependent neoplasia. - active deep vein thrombosis, pulmonary embolism or history of these conditions. - active or recent (e.g., within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction). - liver dysfunction or disease. - depo-estradiol should not be used in patients with known hypersensitivity to its ingredients. - known or suspected pregnancy. there is no indication for depo-estradiol in pregnancy. there appears to be little or no increased risk of birth defects in children born to women who have used estrogens and progestins from oral contraceptives inadvertently during early pregnancy. (see precautions.) chlorobu

United States - English - NLM (National Library of Medicine)

noven therapeutics, llc - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e), norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - estradiol 0.05 mg in 1 d - combipatch is indicated in a woman with a uterus for: - treatment of moderate to severe vasomotor symptoms due to menopause. - treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. - treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure. combipatch is contraindicated in women with any of the following conditions: - undiagnosed abnormal genital bleeding. - known, suspected, or history of breast cancer. - known or suspected estrogen-dependent neoplasia. - active dvt, pe, or history of these conditions. - active arterial thromboembolic disease (for example, stroke and mi), or a history of these conditions. - known anaphylactic reaction or angioedema or hypersensitivity with combipatch. - known liver impairment or disease. - known protein c, protein s, or antithrombin deficiency, or other known thrombophilic disorders. - known or suspected pregnancy. combipatch (käm-bē `pach) (estradiol/norethindrone acetate transdermal system) step 1. pick the days you will change your combipatch. - you will need to change your patch every 3 to 4 days (twice weekly). step 2. remove combipatch from the pouch. - tear open the protective pouch at the slit (do not use scissors) and remove the patch. see figure a. - the pouch should not be opened until you are ready to put the patch on. step 3. remove the adhesive liner. - peel off one side of the protective liner. see figure b. - do not touch the sticky part of the patch with your fingers. see figure b. step 4. placing the combipatch on your skin. - put the sticky side of the patch on the lower abdomen (below the panty line). see figure c. - peel off the second side of the protective liner. see figure c. - press the patch firmly in place with your hand for about 10 seconds. see figure d. note: - avoid the waistline, since clothing and belts may cause the combipatch to be rubbed off. - do not apply the combipatch to or near your breasts. - only apply the combipatch to skin that is clean, dry, and free of any powder, oil, or lotion. - you should not apply the combipatch to injured, burned, or irritated skin, or areas with skin conditions (such as birth marks, tattoos, or that is very hairy). step 5. press the combipatch firmly onto your skin. - rub the edges of the combipatch with your fingers to make sure that it will stick to your skin. see figure e. note: - bathing, swimming, or showering will not affect the combipatch. - once in place, the patch should not be exposed to the sun for prolonged periods of time. - if your combipatch falls off reapply it. if you cannot reapply the combipatch, apply a new combipatch to another area (see figures c , d and e) and continue to follow your original placement schedule. - if you stop using your combipatch or forget to apply a new combipatch as scheduled you may have spotting, or bleeding, and your symptoms may come back. step 6. throwing away your used combipatch. - when it is time to change your combipatch, remove the old combipatch before you apply a new one. - to throw away the patch, fold the sticky side of the patch together, place it in a sturdy child-proof container, and place this container in the trash. used patches should not be flushed in the toilet. this patient information and instructions for use have been approved by the u.s. food and drug administration. manufactured by: noven pharmaceuticals inc. miami, fl 33186 distributed by: noven therapeutics, llc miami, fl 33186 for more information call 1-800-455-8070 or visit www.combipatch.com. © 2024 noven pharmaceuticals, inc. 102538-5 02/2024

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbott healthcare products ltd - estradiol - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbott healthcare products ltd - estradiol - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kyowa kirin ltd - estradiol - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - estradiol - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novo nordisk ltd - estradiol - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novo nordisk ltd - estradiol - oral tablet - 1mg